Company: NIVFW
Filing Date: 2025-04-22
Form Type: 20-F
Source: 0001213900-25-033966
Chunk: 35

Company: NewGenIvf Group Ltd
Filing Date: 2025-04-22
Form: 20-F
Item: Item 3
Chunk 35
---
, regulations, guidance and contractual provisions related to or impacting the
healthcare industry that may apply to its business activities directly or indirectly, including, but not limited to:

  Licensing and Licensed Personnel. Many countries have licensure or registration requirements for entities acting as a medical services provider. The scope of these laws differs from country to ...  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  Patients’ Right Protection. There has been an increased awareness of patients’ rights in Thailand, Cambodia and Kyrgyzstan, especially with the issuance of the Constitution of the Kingdom of Th...  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

Meanwhile, Thailand is considering
enacting a Patient Protection Bill (the “ Bill”). The Bill, if issued, is intended to alleviate disputes between patients and
healthcare providers, which have an impact on the healthcare system in Thailand as a whole. The compensation outlined in the Bill will
assist patients in claiming damages, thereby fostering a positive relationship between patients and healthcare providers. Consequently,
the rate of disputes is expected to decrease. The provisions under the Bill would require healthcare providers to compensate patients
in a timely manner, sometimes without requiring proof of wrongdoing. The Bill also contemplates setting up a patient protection fund for
damages to patients pursuant to which healthcare providers have to make mandatory contributions according to the rules determined by a
patient protection committee. Failure by it to comply with applicable rules and regulations could result in penalties, the loss of regulatory
permits and damage to NewGenIvf’s business reputation, each of which could have a material adverse effect on its financial condition
and results of operations.

Furthermore, the Protection of A Child
Born By Medically Assisted Reproductive Technology Act B. E. 2558 (2015) of Thailand was promulgated with the intention to appropriately
designate the legitimate parenthood status of a child born using medically assisted reproductive technology and regulate any medical
scientific research on embryology and medically assisted reproductive technologies to prevent the misuse of medically assisted reproductive
technologies. NewGenIvf is therefore under the supervision of a Committee of the Protection for Children Born through Medically Assisted
Reproductive Technology, which is a committee established to control, inspect, supervise and formulate various policies relating to such
acts. In Cambodia and Kyrgyzstan, all health